Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for perioperative inflammatory response to major thoracic or abdominal surgery
ACTRN12615000041550Phase 2Completed
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of celecoxib in post-operative inflammation and acute postoperative pain (2 arms), sponsored by Peter MacCallum Cancer Centre. Primary endpoints: Plasma prostaglandin E metabolite change and Urine prostaglandin E metabolite change. Started Feb 2015; status: completed.
02
Drugs
celecoxib
03
Conditions
post-operative inflammationacute postoperative pain
Beyond the preview
Go deeper on ACTRN12615000041550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000041550.